Merck & Co., Inc. (MRK)
Total Valuation
Merck & Co. has a market cap or net worth of $239.05 billion. The enterprise value is $261.92 billion.
| Market Cap | 239.05B |
| Enterprise Value | 261.92B |
Important Dates
The latest earnings date was Thursday, April 28, 2022, before market open.
| Last Earnings Date | Apr 28, 2022 |
| Ex-Dividend Date | Jun 14, 2022 |
Share Statistics
Merck & Co. has 2.57 billion shares outstanding. The number of shares has decreased by -0.10% in one year.
| Shares Outstanding | 2.57B |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 75.15% |
| Float | 2.53B |
Valuation Ratios
The trailing PE ratio is 16.66 and the forward PE ratio is 12.58. Merck & Co.'s PEG ratio is 1.17.
| PE Ratio | 16.66 |
| Forward PE | 12.58 |
| PS Ratio | 4.43 |
| PB Ratio | 5.85 |
| P/FCF Ratio | 18.70 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.49, with a EV/FCF ratio of 20.49.
| EV / Earnings | 18.47 |
| EV / Sales | 4.85 |
| EV / EBITDA | 13.49 |
| EV / EBIT | 16.35 |
| EV / FCF | 20.49 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.40 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 2.49 |
Financial Efficiency
Return on equity (ROE) is 38.30%, which is very high. The company has a high ROIC of 27.40%.
| Return on Equity (ROE) | 38.30% |
| Return on Assets (ROA) | 14.30% |
| Return on Capital (ROIC) | 27.40% |
| Revenue Per Employee | $805,642 |
| Profits Per Employee | $211,642 |
| Employee Count | 67,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, Merck & Co. has paid $1.84 billion in taxes.
| Income Tax | 1.84B |
| Effective Tax Rate | 11.47% |
Stock Price Statistics
The stock price has increased by +20.17% in the last 52 weeks. The beta is 0.37, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (1Y) | 0.37 |
| 52-Week Price Change | +20.17% |
| 50-Day Moving Average | 88.57 |
| 200-Day Moving Average | 80.53 |
| Average Volume (30 Days) | 11,467,338 |
Short Selling Information
The latest short interest is 16.98 million, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 16.98M |
| Short % of Shares Out | 0.66% |
| Short % of Float | 0.67% |
| Short Ratio (days to cover) | 1.45 |
Income Statement
In the last 12 months, Merck & Co. had revenue of $53.98 billion and earned 14.18 billion in profits. Earnings per share was $5.59.
| Revenue | 53.98B |
| Gross Profit | 38.17B |
| Operating Income | 15.57B |
| Pretax Income | 16.02B |
| Net Income | 14.18B |
| EBITDA | 19.42B |
| EBIT | 16.02B |
| Earnings Per Share (EPS) | $5.59 |
Balance Sheet
The company has $8.93 billion in cash and $31.79 billion in debt, giving a net cash position of -$22.87 billion or -$8.90 per share.
| Cash & Cash Equivalents | 8.93B |
| Total Debt | 31.79B |
| Net Cash | -22.87B |
| Net Cash Per Share | -$8.90 |
| Book Value | 40.88B |
| Book Value Per Share | 15.92 |
| Working Capital | 8.87B |
Cash Flow
In the last 12 months, operating cash flow was $17.08 billion and capital expenditures -$4.30 billion, giving a free cash flow of $12.78 billion.
| Operating Cash Flow | 17.08B |
| Capital Expenditures | -4.30B |
| Free Cash Flow | 12.78B |
| FCF Per Share | $4.98 |
Margins
Gross margin is 70.71%, with operating and profit margins of 28.85% and 26.27%.
| Gross Margin | 70.71% |
| Operating Margin | 28.85% |
| Pretax Margin | 29.67% |
| Profit Margin | 26.27% |
| EBITDA Margin | 35.98% |
| EBIT Margin | 29.67% |
| FCF Margin | 23.68% |
Dividends & Yields
This stock pays an annual dividend of $2.68, which amounts to a dividend yield of 2.88%.
| Dividend Per Share | $2.68 |
| Dividend Yield | 2.88% |
| Earnings Yield | 5.93% |
| FCF Yield | 5.35% |
| Dividend Growth (YoY) | 6.15% |
| Payout Ratio | 47.80% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.88% |
Analyst Forecast
The average price target for Merck & Co. is $97.64, which is 4.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $97.64 |
| Price Target Difference | 4.90% |
| Analyst Consensus | Buy |
| Analyst Count | 34 |
Stock Splits
The last stock split was on June 3, 2021. It was a forward split with a ratio of 1048:1000.
| Last Split Date | Jun 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1048:1000 |